TOP stocks:

Apple

Shares of other companies:

United Rentals Inc

Eaton Corporation PLC

Vinco Ventures

Chipotle Mexican Grill

Charter Communications

Forecast: (HAE) for today October 26 & Weekly Forecast from 22 October to 28 October

Updated: October 26, 2023

Brief information about Haemonetics Corporation

Ticker: HAE

Sector: Healthcare

Closing price of the last trading day: $87.83

Last trading day: 10/24/2023

Analyst forecast price: $75.67

52-week high/low: $75.34 / $43.5

Shares of Haemonetics Corporation are traded on the stock exchange under the ticker HAE, marking their space in the competitive "Healthcare" sector. For stakeholders, tracking the dynamic price movement of HAE is crucial for making informed investment decisions. In a market influenced by myriad factors, predicting the trajectory of these shares becomes both a challenge and a necessity. Predictive analytics and data-driven insights play a pivotal role in forecasting the performance of HAE. The investors seeking up-to-date and accurate forecasts for Haemonetics Corporation shares can turn to resources like Allforecast.com. The website stands out as a reliable tool offering real-time predictions, ensuring that investors are equipped with current and anticipated stock trends. On Allforecast.com, users gain access to a comprehensive analysis and predictions specifically tailored for HAE, spanning varied timeframes - from the next day's anticipations to weekly, monthly, and yearly forecasts. The platform’s real-time updating mechanism ensures that the forecasted data aligns with the ongoing market trends and economic shifts, offering users actionable insights to optimize their investment strategies. The forecasts integrate a mix of qualitative and quantitative analyses, sector-specific trends within "Healthcare", and broader market dynamics to present a holistic view of HAE's expected performance. By leveraging such precise and timely data, investors can strategize their moves, balancing risks and opportunities associated with Haemonetics Corporation's stocks. Navigating through the unpredictable terrains of the stock market requires actionable insights and timely data. Allforecast.com serves as a companion for investors eyeing HAE, offering them a blend of accuracy and timeliness in predicting stock movements, aiding in informed and strategic investment choices.

Main Headquarters: Situated at 125 SUMMER STREET, BOSTON, MA, US, this location serves as the primary hub for all corporate activities.

Haemonetics's Current Market Value: As of our last update, it's pegged at $3 531 964 000, indicating its standing in the financial landscape.

Shares Overview: Currently, 51 299 000 shares of Haemonetics are actively traded and held by the public.

Last year's EBITDA (Earnings Before Interest, Taxes, and Depreciation) for Haemonetics stood at 211 156 000$. This figure provides insights into the company's operational profitability. With this positive EBITDA, Haemonetics showcases a favorable financial health.

The PE ratio according to the latest reporting is at around 81.96. P/E shows the investor how many years his investment in this business pays off. That is, investments in Haemonetics shares will pay off in about 82 years. A very long payback period of investments, shares should be considered not as an investment idea, but as a speculative one.

In addition to fundamental factors, stocks are influenced by many other factors. For example, it is worth monitoring all global forecasts for Haemonetics shares. Our service will help you with this, in which we collect all forecasts and build one consensus forecast from them.

Haemonetics stock forecast

When considering an investment in Haemonetics, prospective investors often seek insights on its long-term performance. Our platform consolidates the expert analyses and projections from renowned global analysts to offer a unified consensus forecast for 2023, 2024, 2025, 2026, and 2027.

With these forecasts at your disposal, you can address critical questions like:

What will be the price of one share of Haemonetics in the subsequent years including 2023, 2024, 2025, 2026, and 2027?

What consensus have the analysts reached regarding the future performance of Haemonetics stock?

Is Haemonetics stock a viable option for both short-term and long-term investment?

Is it prudent to sell or hold Haemonetics shares in 2023?

Is 2023 the opportune moment to buy Haemonetics stock, or is patience a more viable strategy?

What are the anticipated entry and exit points for investing in Haemonetics stock, according to expert forecasts?

It’s pivotal to remember that these forecasts are to be utilized as informational resources and not definitive investment advice. The final investment decision rests solely upon the investor, contingent on their risk tolerance, investment goals, and thorough analysis of Haemonetics.

Insight into Our Forecasting Process

Our forecasting methodology encompasses the aggregation of public and expert data on Haemonetics, coupled with a sophisticated algorithm that calculates a weighted average forecast while eliminating outliers. This ensures that our audience receives a refined and realistic projection of Haemonetics stock’s future performance.

Haemonetics Daily Share Price Forecast for One Month

Our team has meticulously gathered and analyzed forecasts from a diverse pool of analysts to present a consolidated average daily forecast for Haemonetics shares over the upcoming month. It’s essential to bear in mind that short-term predictions can often be subject to significant volatility, influenced by a myriad of dynamic, real-time market factors.

As you scroll, you’ll discover a detailed graph illustrating the consensus forecast for Haemonetics stocks over the next 30 days. The gray spectrum of the chart delineates the historical trajectory of the stock’s price, while the turquoise spectrum provides a visual representation of the anticipated price, inclusive of potential fluctuation ranges, offering insights into prospective market trends and stock behaviors.

In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Haemonetics shares. Our integrated forecast predicts a peak price of $101.72 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. An encouraging revelation, denoting an upside potential of 15.81% from the current standing.

On the flip side, the stock might plummet to a minimum of $86.26 within the same period. A decline of 1.82% signals caution, nudging investors towards a more conservative stance.

Consequently, a fluctuation corridor emerges, with the stock’s resistance at $101.72 and support at $86.26, indicating the oscillating nature of Haemonetics’s stock over the one-month spectrum. These oscillations, while providing trading opportunities, should be navigated with adept knowledge and strategic foresight.

So, what’s the trajectory of Haemonetics amidst these projections? The nuances of stock trading and investment are encapsulated in the constant ebb and flow of the market, influenced by intrinsic and extrinsic factors. Hence, a comprehensive, nuanced understanding of market dynamics, coupled with real-time analytics, emerges as the cornerstone for maximizing ROI and mitigating risks.

The evolution of Haemonetics’s stock is akin to a narrative unfolding, shaped by myriad factors including market trends, economic indicators, and investor sentiment. Each fluctuation is a chapter of this narrative, offering insights, challenges, and opportunities to the discerning investor.

Evaluating the resilience of the support level is crucial in gauging the future trajectory of Haemonetics shares. The anticipation is that the price will hover near the support level for 2 days. The support level at $86.26 appears to be resilient. The likelihood of this support level being breached is minimal, indicating a phase of stability for Haemonetics stocks.

It’s imperative to remember the innate unpredictability of the stock market. The actual future value of Haemonetics shares is subject to variables beyond predictive analytics. Nonetheless, investors can expect the stock to oscillate within the defined optimistic and pessimistic target price brackets, offering both challenges and opportunities for strategic trading and investment.

Forecast table for 30 days
Date	Target	Pes.	Opt.	Vol., %
Oct 27	89.72	89.10	90.71	1.81
Oct 28	89.67	88.45	90.42	2.23
Oct 29	90.06	89.51	91.97	2.74
Oct 30	89.43	87.51	91.51	4.56
Oct 31	90.91	90.17	91.97	1.99
Nov 01	91.20	89.09	92.08	3.35
Nov 02	91.23	90.44	92.55	2.34
Nov 03	92.47	91.51	94.30	3.05
Nov 04	94.13	92.31	96.13	4.14
Nov 05	92.14	91.45	92.78	1.46
Nov 06	91.15	90.20	92.58	2.64
Nov 07	92.53	91.48	94.43	3.23
Nov 08	93.95	92.40	94.82	2.62
Nov 09	93.57	91.56	94.90	3.65
Nov 10	95.31	93.87	96.25	2.53
Nov 11	95.55	93.42	97.77	4.66
Nov 12	95.25	93.67	97.32	3.89
Nov 13	96.71	95.68	98.37	2.81
Nov 14	95.87	94.98	97.60	2.75
Nov 15	93.45	91.39	94.02	2.88
Nov 16	93.91	93.10	95.17	2.22
Nov 17	93.10	92.07	94.42	2.55
Nov 18	94.58	93.32	96.01	2.88
Nov 19	96.04	94.59	97.96	3.56
Nov 20	97.59	95.84	99.46	3.78
Nov 21	99.09	96.85	100.70	3.98
Nov 22	99.27	98.58	101.37	2.83
Nov 23	99.04	97.20	100.16	3.04
Nov 24	99.50	97.53	101.72	4.29
Nov 25	99.01	96.80	100.36	3.68

Haemonetics Stock Forecast 27 Oct.

Presumably, on 10/27/2023, the price of shares will be in the range of $89.10 - $90.71. A $1.61 range width can provide 1.81% volatility. The weighted average price of this range is at $89.72, which is $2.50 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 28 Oct.

Presumably, on 10/28/2023, the price of shares will be in the range of $88.45 - $90.42. A $1.98 range width can provide 2.23% volatility. The weighted average price of this range is at $89.67, which is $0.05 lower than the previous day's weighted average price.

Haemonetics Stock Forecast 29 Oct.

Presumably, on 10/29/2023, the price of shares will be in the range of $89.51 - $91.97. A $2.46 range width can provide 2.74% volatility. The weighted average price of this range is at $90.06, which is $0.39 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 30 Oct.

Presumably, on 10/30/2023, the price of shares will be in the range of $87.51 - $91.51. A $3.99 range width can provide 4.56% volatility. The weighted average price of this range is at $89.43, which is $0.63 lower than the previous day's weighted average price.

Haemonetics Stock Forecast 31 Oct.

Presumably, on 10/31/2023, the price of shares will be in the range of $90.17 - $91.97. A $1.79 range width can provide 1.99% volatility. The weighted average price of this range is at $90.91, which is $1.48 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 01 Nov.

Presumably, on 11/01/2023, the price of shares will be in the range of $89.09 - $92.08. A $2.99 range width can provide 3.35% volatility. The weighted average price of this range is at $91.20, which is $0.29 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 02 Nov.

Presumably, on 11/02/2023, the price of shares will be in the range of $90.44 - $92.55. A $2.12 range width can provide 2.34% volatility. The weighted average price of this range is at $91.23, which is $0.03 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 03 Nov.

Presumably, on 11/03/2023, the price of shares will be in the range of $91.51 - $94.30. A $2.79 range width can provide 3.05% volatility. The weighted average price of this range is at $92.47, which is $1.24 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 05 Nov.

Presumably, on 11/05/2023, the price of shares will be in the range of $91.45 - $92.78. A $1.34 range width can provide 1.46% volatility. The weighted average price of this range is at $92.14, which is $1.99 lower than the previous day's weighted average price.

Haemonetics Stock Forecast 06 Nov.

Presumably, on 11/06/2023, the price of shares will be in the range of $90.20 - $92.58. A $2.38 range width can provide 2.64% volatility. The weighted average price of this range is at $91.15, which is $0.99 lower than the previous day's weighted average price.

Haemonetics Stock Forecast 07 Nov.

Presumably, on 11/07/2023, the price of shares will be in the range of $91.48 - $94.43. A $2.95 range width can provide 3.23% volatility. The weighted average price of this range is at $92.53, which is $1.37 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 08 Nov.

Presumably, on 11/08/2023, the price of shares will be in the range of $92.40 - $94.82. A $2.42 range width can provide 2.62% volatility. The weighted average price of this range is at $93.95, which is $1.42 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 09 Nov.

Presumably, on 11/09/2023, the price of shares will be in the range of $91.56 - $94.90. A $3.34 range width can provide 3.65% volatility. The weighted average price of this range is at $93.57, which is $0.38 lower than the previous day's weighted average price.

Haemonetics Stock Forecast 10 Nov.

Presumably, on 11/10/2023, the price of shares will be in the range of $93.87 - $96.25. A $2.38 range width can provide 2.53% volatility. The weighted average price of this range is at $95.31, which is $1.74 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 11 Nov.

Presumably, on 11/11/2023, the price of shares will be in the range of $93.42 - $97.77. A $4.35 range width can provide 4.66% volatility. The weighted average price of this range is at $95.55, which is $0.25 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 12 Nov.

Presumably, on 11/12/2023, the price of shares will be in the range of $93.67 - $97.32. A $3.65 range width can provide 3.89% volatility. The weighted average price of this range is at $95.25, which is $0.30 lower than the previous day's weighted average price.

Haemonetics Stock Forecast 13 Nov.

Presumably, on 11/13/2023, the price of shares will be in the range of $95.68 - $98.37. A $2.69 range width can provide 2.81% volatility. The weighted average price of this range is at $96.71, which is $1.46 higher than the previous day's weighted average price.

Haemonetics Stock Forecast 14 Nov.

Presumably, on 11/14/2023, the price of shares will be in the range of $94.98 - $97.60. A $2.61 range width can provide 2.75% volatility. The weighted average price of this range is at $95.87, which is $0.84 lower than the previous day's weighted average price.

Haemonetics Stock Forecast 15 Nov.

Presumably, on 11/15/2023, the price of shares will be in the range of $91.39 - $94.02. A $2.63 range width can provide 2.88% volatility. The weighted average price of this range is at $93.45, which is $2.42 lower than the previous day's weighted average price.

Table of forecasts for 2023.
Month	Target	Pes.	Opt.	Vol., %
Nov.	85.31	81.22	91.54	11.28
Dec.	88.81	82.50	93.51	11.78

Diving into a more comprehensive insight, the monthly consensus forecast is an instrumental resource for investors eyeing Haemonetics's performance metrics. These projections are meticulously curated, leveraging insights from renowned global analysts and offering a panoramic view of the anticipated stock behaviour for the current year and beyond.

In the mid-term analysis, forecasting accuracy enhances, attributed to the diminished influence of transient market fluctuations. For this year, the zenith of Haemonetics share’s value is anticipated to touch $93.51, offering a robust metric for investment strategies, sans the extremes of varied agency forecasts.

On the contrary, the nadir projections settle at $81.22, delineating the lower threshold and offering a holistic perspective on the risk and return landscape.

Explore Detailed 2023 Forecast

Progressing further, we have extrapolated these analytical insights to generate consensus forecasts for subsequent years. The synthesized data, presented in intuitive tabular formats, offers investors, analysts, and enthusiasts a streamlined view into the future of Haemonetics stocks.

Anticipated Trends: Haemonetics (HAE) Monthly Stock Trajectory for 2024

Table of forecasts for 2024.
Month	Target	Pes.	Opt.	Vol., %
Jan	84.63	81.67	89.97	9.22
Feb	86.58	81.13	92.12	11.94
Mar	82.51	77.64	85.40	9.08
Apr	86.14	80.28	89.85	10.64
May	93.89	90.23	98.40	8.30
Jun	91.08	84.98	96.18	11.65
Jul	88.53	86.58	93.31	7.21
Aug	85.61	83.12	88.00	5.54
Sep	89.89	83.23	92.04	9.57
Oct	86.47	80.68	92.00	12.31
Nov	91.23	86.48	96.15	10.06
Dec	91.32	84.29	96.61	12.76

Detailed forecast for 2024

Haemonetics (HAE) Monthly Stock Prediction for 2025

Table of forecasts for 2025.
Month	Target	Pes.	Opt.	Vol., %
Jan	87.85	85.04	89.60	5.10
Feb	94.26	89.26	101.14	11.74
Mar	94.17	88.99	98.12	9.31
Apr	98.12	93.61	104.30	10.25
May	101.36	99.03	107.54	7.92
Jun	103.99	101.08	111.59	9.41
Jul	108.67	106.28	115.30	7.82
Aug	108.13	102.94	113.00	8.90
Sep	105.10	100.79	111.51	9.61
Oct	114.88	110.05	121.89	9.71
Nov	120.85	111.18	126.53	12.13
Dec	125.69	122.17	130.34	6.27

Detailed forecast for 2025

Haemonetics (HAE) Monthly Stock Prediction for 2026

Table of forecasts for 2026.
Month	Target	Pes.	Opt.	Vol., %
Jan	131.34	123.46	134.63	8.29
Feb	132.79	129.07	136.77	5.63
Mar	137.04	132.92	147.18	9.68
Apr	138.95	127.84	149.93	14.74
May	130.34	127.08	136.46	6.88
Jun	124.73	120.74	130.22	7.28
Jul	134.34	128.29	137.83	6.92
Aug	146.83	135.82	153.29	11.40
Sep	155.79	144.57	160.15	9.73
Oct	159.37	153.00	171.48	10.78
Nov	174.19	162.87	186.74	12.78
Dec	176.28	170.47	185.63	8.17

Detailed forecast for 2026

Haemonetics (HAE) Monthly Stock Prediction for 2027

Table of forecasts for 2027.
Month	Target	Pes.	Opt.	Vol., %
Jan	189.15	179.88	200.69	10.37
Feb	182.34	173.96	192.01	9.40
Mar	171.04	167.10	175.83	4.96
Apr	170.18	158.95	175.29	9.32
May	164.74	152.22	171.16	11.07
Jun	176.10	167.83	181.92	7.74
Jul	188.78	178.97	203.89	12.22
Aug	183.12	168.65	187.51	10.06
Sep	176.89	173.18	185.03	6.40
Oct	182.55	169.59	195.70	13.34
Nov	192.96	185.24	199.52	7.16
Dec	197.21	188.33	212.39	11.33

Detailed forecast for 2027

Denial of responsibility:

All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them to a single whole. The portal allforecast.com is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

Forecast: (HAE) for today October 26 & Weekly Forecast from 22 October to 28 October

Brief information about Haemonetics Corporation